Madrigal Pharmaceuticals, Inc. (MDGL) Investment Research Dashboard
About Madrigal Pharmaceuticals, Inc. (MDGL) stock analysis
Get live MDGL stock price $551.25, comprehensive Madrigal Pharmaceuticals, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time MDGL stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced ...
Company Information
- CEO
- William J. Sibold
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 915
Contact Information
- Address
- Four Tower Bridge
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -1.06) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Madrigal Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Madrigal Pharmaceuticals, Inc.
- ⚠Investors should consider how Madrigal Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
12.71B
P/E Ratio (TTM)
-43.07
Beta
-1.06
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MDGL with peer companies:
- Price
- $128.00+1.83% (1D)
- Market cap
- 9.40B
- Price
- $23.34+4.20% (1D)
- Market cap
- 12.05B
- Price
- $60.27+1.58% (1D)
- Market cap
- 11.65B
- Price
- $15.63+0.71% (1D)
- Market cap
- 4.42B
- Price
- $55.81+0.79% (1D)
- Market cap
- 14.03B
- Price
- $255.43+0.61% (1D)
- Market cap
- 16.05B
- Price
- $55.63+2.89% (1D)
- Market cap
- 22.07B
- Price
- $11.57+0.70% (1D)
- Market cap
- 197.91M
- Price
- $106.13+3.95% (1D)
- Market cap
- 7.28B
- Price
- $71.62+0.03% (1D)
- Market cap
- 11.21B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- -0.1%
- NASDAQ
- -0.1%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.